{"id":52611,"date":"2024-03-23T17:32:33","date_gmt":"2024-03-23T17:32:33","guid":{"rendered":"https:\/\/medgyd.lt\/cc\/budesonide-formoterol-teva-pharma-b-v-160-%c2%b5g-45-%c2%b5g-dozuoti-ikvepiamieji-milteliai-120-doziu-n1-25293\/"},"modified":"2024-03-23T17:32:33","modified_gmt":"2024-03-23T17:32:33","slug":"budesonide-formoterol-teva-pharma-b-v-160-%c2%b5g-45-%c2%b5g-dozuoti-ikvepiamieji-milteliai-120-doziu-n1-25293","status":"publish","type":"post","link":"https:\/\/medgyd.lt\/cc\/budesonide-formoterol-teva-pharma-b-v-160-%c2%b5g-45-%c2%b5g-dozuoti-ikvepiamieji-milteliai-120-doziu-n1-25293\/","title":{"rendered":"Budesonide\/Formoterol Teva Pharma B.V. 160 \u00b5g\/4,5 \u00b5g dozuoti \u012fkvepiamieji milteliai 120 dozi\u0173 N1"},"content":{"rendered":"<h1>Detali informacija apie Budesonide\/Formoterol Teva Pharma B.V. 160 \u00b5g\/4,5 \u00b5g<\/h1>\n<p>&nbsp;<\/p>\n<p><strong>Veiklioji med\u017eiaga:<\/strong> Budezonidas\/Formoterolis<\/p>\n<p><strong>Veikliosios med\u017eiagos koncentracija:<\/strong> 160 \u00b5g\/4,5 \u00b5g<\/p>\n<p><strong>Vartojimo b\u016bdas:<\/strong> \u012fkv\u0117pti<\/p>\n<p><strong>Vaistinio preparato grup\u0117:<\/strong> Vaistinis preparatas<\/p>\n<p><strong>Kitos vaisto dozuot\u0117s: <\/strong>120 dozi\u0173 N1<strong><br \/>\n<\/strong><\/p>\n<p><strong>Vaistinio preparato pogrupis:<\/strong> Cheminis<\/p>\n<p><strong>Recepto poreikis:<\/strong> Receptinis<\/p>\n<p><strong>Preparato ATC kodas:<\/strong> R03AK07<\/p>\n<p><strong>Pakuot\u0117s tipas:<\/strong> inhaliatorius<\/p>\n<p><strong>Dozuot\u0117 pakuot\u0117je:<\/strong> 120 dozi\u0173 N1<\/p>\n<p><strong>Vaisto stadija:<\/strong> I\u0161registruotas 2014-11-19 EU\/1\/14\/950\/001<\/p>\n<p><strong>Registruotojas: <\/strong>TEVA Pharma B.V..<\/p>\n<p><strong>Perregistravimo data: <\/strong><\/p>\n<p><strong>Registracijos \u0161alis: <\/strong>Nyderlandai<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Budesonide\/Formoterol Teva Pharma B.V. sud\u0117tyje yra: Budezonidas\/Formoterolis &#8211; 160 \u00b5g\/4,5 \u00b5g dozuoti \u012fkvepiamieji milteliai. Preparatas skirtas vartoti \u012fkv\u0117pti. Receptinis preparatas. Pakuot\u0119 sudaro 120 dozi\u0173 N1 inhaliatorius<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[16222,16223,6,4,5],"tags":[16224,12960,120,1995,119],"class_list":["post-52611","post","type-post","status-publish","format-standard","hentry","category-budesonide-formoterol-teva-pharma-b-v","category-budesonide-formoterol-teva-pharma-b-v-160-g-45-g","category-cheminis","category-vaistai","category-vaistinis-preparatas-vaistai","tag-budesonide-formoterol-teva-pharma-b-v","tag-budezonidas-formoterolis","tag-cheminis","tag-dozuoti-ikvepiamieji-milteliai","tag-receptinis"],"_links":{"self":[{"href":"https:\/\/medgyd.lt\/cc\/wp-json\/wp\/v2\/posts\/52611","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medgyd.lt\/cc\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medgyd.lt\/cc\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medgyd.lt\/cc\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/medgyd.lt\/cc\/wp-json\/wp\/v2\/comments?post=52611"}],"version-history":[{"count":0,"href":"https:\/\/medgyd.lt\/cc\/wp-json\/wp\/v2\/posts\/52611\/revisions"}],"wp:attachment":[{"href":"https:\/\/medgyd.lt\/cc\/wp-json\/wp\/v2\/media?parent=52611"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medgyd.lt\/cc\/wp-json\/wp\/v2\/categories?post=52611"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medgyd.lt\/cc\/wp-json\/wp\/v2\/tags?post=52611"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}